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Last week more than 400 public health doctors, specialists, and academics from 
across the country wrote an open letter to the House of Lords stating that the Health 
and Social Care Bill will do “irreparable harm to the NHS, to individual patients, and 
to society as a whole,” that it will “erode the NHS’s ethical and cooperative 
foundations,” and that it will “not deliver efficiency, quality, fairness, or choice.”1 
  
The prime minister claimed that the letter actually supported aspects of the bill, 
while the secretary of state for health was dismissive, maintaining that people 
signed it without reading it and that it was “politically motivated” and unsupported 
by “a shred of evidence.” 
  
 These claims were wrong. There was no qualified support for the bill. Nor did 
signatories write in a political capacity: they wrote in their professional capacity and 
with the public interest in mind. Nor are public health professionals alone in having 
concerns: the public, the BMA, and many of the royal colleges continue to express 
deep and continuing concerns. 
Public health professionals are responsible for assessing the healthcare needs of the 
entire population. This entails looking across the entire health system to ensure that 
its different components come together efficiently, effectively, and fairly. They are 
expected to speak out as advocates for the population and especially for those 
people with poorer health outcomes. But more importantly, our concerns are based 
on a wealth of evidence, much published in peer reviewed journals.2 3 4 5 
 
There are many problems with the bill. For one, it abolishes direct accountability of 
the secretary of state for health to secure comprehensive care for the whole 
population and the mechanisms and structures for securing that duty.6 The health 
secretary has also stated that equitable resource allocation will no longer be his 
direct responsibility and that national resource allocation formulas will change from 
area based populations to GP registrations, a move that portends a shift towards a 
model of competing insurance pools or funds, for which the evidence from other 
countries is adverse.7 8 
 
  
The bill will usher in a new era of commercialisation but still does not make clear 
the public duties of the economic regulator, Monitor. And while the proposed duties 
of clinical commissioning groups remain weak, they will be given the freedom to 
compete for or select their registered populations, as well as “flexibilities” in 
defining which services to provide. Allowing clinical commissioning groups to also 
enter into joint ventures with private companies will create inequalities in 
entitlement to care and introduce commercial conflicts of interest.9 
  
New commercial actors will be driven to compete and maximise income, 
overshadowing the need to cooperate and collaborate in ways that place the patient 
and population at the heart of the health system. The absence of clear 
responsibilities for geographically defined populations will make it difficult, if not 
impossible, to link clinical NHS commissioning with social care services or with 
plans and interventions to act on the social determinants of health. 
  
While we value clinical engagement in population based planning and 
commissioning, the more important problem is that the bill hands over greater 
control over public budgets to the dictates of the market. We believe that most 
healthcare professions reject this proposed transformation and are aware of the 
clinical, professional, and ethical shortcomings of market based health systems such 
as those that exist in the United States.10 
  
The health secretary has called for a debate that is based on evidence. We agree. But 
this requires transparency about the evidence base and the intentions that have 
shaped the bill. So far, the proposed structures do not conform to the goal of a 
universal and equitable health service, free at the point of delivery, and accessed on 
the basis of need and not ability to pay. 
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